Quoin Pharmaceuticals, Ltd.

QNRX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$9-$9-$9-$21
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$1$1$1$0
Change in WC-$0$0-$0$1
Other Non-Cash-$0-$0$0$15
Operating Cash Flow-$8-$8-$8-$6
Investing Activities
PP&E Inv.$0$0-$0-$1
Net Acquisitions$0$0$0$0
Inv. Purchases-$17,254-$18-$10$0
Inv. Sales/Matur.$26,934$20$14,877$0
Other Inv. Act.-$9,681$0-$14,877$0
Investing Cash Flow-$2$2-$10-$1
Financing Activities
Debt Repay.-$1-$1-$0$3
Stock Issued$12$6$15$0
Stock Repurch.$0$0-$15$0
Dividends Paid$0$0-$65$0
Other Fin. Act.-$0-$0$65$10
Financing Cash Flow$11$5$14$14
Forex Effect$0$0$0$0
Net Chg. in Cash$1-$0-$5$7
Supplemental Information
Beg. Cash$2$3$7$0
End Cash$4$2$3$7
Free Cash Flow-$8-$8-$9-$6